請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/104658完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李芳仁 | zh_TW |
| dc.contributor.advisor | Fang-Jen Lee | en |
| dc.contributor.author | 張庭瑋 | zh_TW |
| dc.contributor.author | Ting-Wei Chang | en |
| dc.date.accessioned | 2026-08-31T16:07:40Z | - |
| dc.date.available | 2026-09-01 | - |
| dc.date.copyright | 2026-08-31 | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-06-26 00:00:00 | - |
| dc.identifier.citation | 1. Takai, Y., T. Sasaki, and T. Matozaki, Small GTP-binding proteins. Physiological reviews, 2001. 81(1): p. 153-208.
2. Cherfils, J. and M. Zeghouf, Regulation of small gtpases by gefs, gaps, and gdis. Physiological reviews, 2013. 93(1): p. 269-309. 3. Wennerberg, K., K.L. Rossman, and C.J. Der, The Ras superfamily at a glance. Journal of cell science, 2005. 118(5): p. 843-846. 4. Mizuno-Yamasaki, E., F. Rivera-Molina, and P. Novick, GTPase networks in membrane traffic. Annual review of biochemistry, 2012. 81(1): p. 637-659. 5. Narumiya, S., The small GTPase Rho: cellular functions and signal transduction. The Journal of Biochemistry, 1996. 120(2): p. 215-228. 6. Crosas-Molist, E., et al., Rho GTPase signaling in cancer progression and dissemination. Physiological Reviews, 2022. 102(1): p. 455-510. 7. Arrazola Sastre, A., et al., Small GTPases of the Ras and Rho families switch on/off signaling pathways in neurodegenerative diseases. International journal of molecular sciences, 2020. 21(17): p. 6312. 8. Qu, L., et al., The ras superfamily of small gtpases in non-neoplastic cerebral diseases. Frontiers in molecular neuroscience, 2019. 12: p. 121. 9. Burd, C.G., T.I. Strochlic, and S.R.G. Setty, Arf-like GTPases: not so Arf-like after all. Trends in cell biology, 2004. 14(12): p. 687-694. 10. Sztul, E., et al., ARF GTPases and their GEFs and GAPs: concepts and challenges. Molecular biology of the cell, 2019. 30(11): p. 1249-1271. 11. Liu, Y., R.A. Kahn, and J.H. Prestegard, Structure and membrane interaction of myristoylated ARF1. Structure, 2009. 17(1): p. 79-87. 12. Wang, B., et al., Protein N-myristoylation: functions and mechanisms in control of innate immunity. Cellular & Molecular Immunology, 2021. 18(4): p. 878-888. 13. Gillingham, A.K. and S. Munro, The small G proteins of the Arf family and their regulators. Annu. Rev. Cell Dev. Biol., 2007. 23(1): p. 579-611. 14. Kaczmarek, B., J.M. Verbavatz, and C.L. Jackson, GBF1 and Arf1 function in vesicular trafficking, lipid homoeostasis and organelle dynamics. Biology of the Cell, 2017. 109(12): p. 391-399. 15. Sabe, H., Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. Journal of biochemistry, 2003. 134(4): p. 485-489. 16. Lu, L., et al., Regulation of Golgi structure and function by ARF-like protein 1 (Arl1). Journal of cell science, 2001. 114(24): p. 4543-4555. 17. Zhou, C., et al., Arl2 and Arl3 regulate different microtubule-dependent processes. Molecular biology of the cell, 2006. 17(5): p. 2476-2487. 18. Fisher, S., et al., ARF family GTPases with links to cilia. American Journal of Physiology-Cell Physiology, 2020. 19. Wiens, C.J., et al., Bardet-Biedl syndrome-associated small GTPase ARL6 (BBS3) functions at or near the ciliary gate and modulates Wnt signaling. Journal of Biological Chemistry, 2010. 285(21): p. 16218-16230. 20. Lin, C.-Y., et al., ARL4, an ARF-like protein that is developmentally regulated and localized to nuclei and nucleoli. Journal of Biological Chemistry, 2000. 275(48): p. 37815-37823. 21. Zhang, J., et al., Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer. Biomedicine & Pharmacotherapy, 2020. 125: p. 110000. 22. Casalou, C., A. Ferreira, and D.C. Barral, The role of ARF family proteins and their regulators and effectors in cancer progression: a therapeutic perspective. Frontiers in cell and developmental biology, 2020. 8: p. 217. 23. Chen, Q., et al., ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN‐deficient primary human glioblastoma. The Journal of pathology, 2019. 247(2): p. 266-278. 24. Chang, T.-W., et al., The phosphorylation of Pak1 by Erk1/2 to drive cell migration requires Arl4D acting as a scaffolding protein. Journal of Cell Science, 2025. 138(10): p. jcs263812. 25. Li, C.-C., et al., ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling. Molecular biology of the cell, 2007. 18(11): p. 4420-4437. 26. Lin, S.-J., et al., Endosomal Arl4A attenuates EGFR degradation by binding to the ESCRT-II component VPS36. Nature Communications, 2023. 14(1): p. 7859. 27. Chiang, T.-S., H.-F. Wu, and F.-J.S. Lee, ADP-ribosylation factor–like 4C binding to filamin-A modulates filopodium formation and cell migration. Molecular biology of the cell, 2017. 28(22): p. 3013-3028. 28. Lin, M.-C., C.-J. Yu, and F.-J.S. Lee, Phosphorylation of Arl4A/D promotes their binding by the HYPK chaperone for their stable recruitment to the plasma membrane. Proceedings of the National Academy of Sciences, 2022. 119(30): p. e2207414119. 29. Chen, K.-J., et al., Cooperative recruitment of Arl4A and Pak1 to the plasma membrane contributes to sustained Pak1 activation for cell migration. Journal of cell science, 2020. 133(3): p. jcs233361. 30. Muratcioglu, S., et al., GTP-dependent K-Ras dimerization. Structure, 2015. 23(7): p. 1325-1335. 31. Simanshu, D.K., M.R. Philips, and J.F. Hancock, Consensus on the RAS dimerization hypothesis: Strong evidence for lipid-mediated clustering but not for G-domain-mediated interactions. Molecular cell, 2023. 83(8): p. 1210-1215. 32. Nan, X., et al., Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway. Proceedings of the National Academy of Sciences, 2015. 112(26): p. 7996-8001. 33. Rezatabar, S., et al., RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. Journal of cellular physiology, 2019. 234(9): p. 14951-14965. 34. Yamaguchi, H., et al., Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil. Structure, 2006. 14(3): p. 589-600. 35. Gollwitzer, P., et al., A Rag GTPase dimer code defines the regulation of mTORC1 by amino acids. Nature cell biology, 2022. 24(9): p. 1394-1406. 36. Diestelkoetter‐Bachert, P., et al., Structural characterization of an Arf dimer interface: molecular mechanism of Arf‐dependent membrane scission. FEBS letters, 2020. 594(14): p. 2240-2253. 37. Matthews, J.M. and M. Sunde, Dimers, oligomers, everywhere. Protein Dimerization and Oligomerization in Biology, 2012: p. 1-18. 38. Esposito, D., et al., H-NS oligomerization domain structure reveals the mechanism for high order self-association of the intact protein. Journal of molecular biology, 2002. 324(4): p. 841-850. 39. Allende, J.E., GTP‐mediated macromolecular interactions: the common features of different systems. The FASEB journal, 1988. 2(8): p. 2356-2367. 40. Langosch, D. and I.T. Arkin, Interaction and conformational dynamics of membrane‐spanning protein helices. Protein Science, 2009. 18(7): p. 1343-1358. 41. Yao, D., et al., P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer. Theranostics, 2020. 10(21): p. 9741. 42. Kumar, R., A.E. Gururaj, and C.J. Barnes, p21-activated kinases in cancer. Nature Reviews Cancer, 2006. 6(6): p. 459-471. 43. Zhao, Z.-s. and E. Manser, PAK family kinases: Physiological roles and regulation. Cellular logistics, 2012. 2(2): p. 59-68. 44. Delorme-Walker, V.D., et al., Pak1 regulates focal adhesion strength, myosin IIA distribution, and actin dynamics to optimize cell migration. Journal of Cell Biology, 2011. 193(7): p. 1289-1303. 45. Lu, W. and B.J. Mayer, Mechanism of activation of Pak1 kinase by membrane localization. Oncogene, 1999. 18(3): p. 797-806. 46. Chong, C., et al., The mechanism of PAK activation: autophosphorylation events in both regulatory and kinase domains control activity. Journal of Biological Chemistry, 2001. 276(20): p. 17347-17353. 47. Zhao, Z.-s. and E. Manser, PAK and other Rho-associated kinases–effectors with surprisingly diverse mechanisms of regulation. Biochemical Journal, 2005. 386(2): p. 201-214. 48. Guo, Y.-J., et al., ERK/MAPK signalling pathway and tumorigenesis. Experimental and therapeutic medicine, 2020. 19(3): p. 1997-2007. 49. Sun, Y., et al., Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. Journal of Receptors and Signal Transduction, 2015. 35(6): p. 600-604. 50. Yao, Z. and R. Seger, The molecular mechanism of MAPK/ERK inactivation. Current Genomics, 2004. 5(4): p. 385-393. 51. Kolch, W., Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nature reviews Molecular cell biology, 2005. 6(11): p. 827-837. 52. Casar, B. and P. Crespo, ERK signals: scaffolding scaffolds? Frontiers in Cell and Developmental Biology, 2016. 4: p. 49. 53. Yao, Z. and R. Seger, The ERK signaling cascade—views from different subcellular compartments. Biofactors, 2009. 35(5): p. 407-416. 54. Sundberg-Smith, L.J., et al., Adhesion stimulates direct PAK1/ERK2 association and leads to ERK-dependent PAK1 Thr212 phosphorylation. Journal of Biological Chemistry, 2005. 280(3): p. 2055-2064. 55. Eitzen, G., et al., Structure and function of the Fgd family of divergent FYVE domain proteins. Biochemistry and Cell Biology, 2019. 97(3): p. 257-264. 56. Chen, Z., et al., Modulation of a GEF switch: autoinhibition of the intrinsic guanine nucleotide exchange activity of p115‐RhoGEF. Protein science, 2011. 20(1): p. 107-117. 57. Orrico, A., et al., Unusually severe expression of craniofacial features in Aarskog‐Scott syndrome due to a novel truncating mutation of the FGD1 gene. American Journal of Medical Genetics Part A, 2007. 143(1): p. 58-63. 58. Orrico, A., et al., Phenotypic and molecular characterisation of the Aarskog–Scott syndrome: a survey of the clinical variability in light of FGD1 mutation analysis in 46 patients. European Journal of Human Genetics, 2004. 12(1): p. 16-23. 59. Wang, H., C. Zhang, and H. Xiao, Mechanism of membrane fusion: protein-protein interaction and beyond. International Journal of Physiology, Pathophysiology and Pharmacology, 2019. 11(6): p. 250. 60. Shattil, S.J. and M.H. Ginsberg, Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology. The Journal of clinical investigation, 1997. 100(1): p. 1-5. 61. Anderluh, A., et al., Direct PIP2 binding mediates stable oligomer formation of the serotonin transporter. Nature communications, 2017. 8(1): p. 14089. 62. Ge, Y., et al., Novel variant in the FGD1 gene causing Aarskog-Scott syndrome. Experimental and Therapeutic Medicine, 2017. 13(6): p. 2623-2628. 63. Chen, C.-T., et al., TBC1D15 functions as an Arl4D GAP and promotes the mitochondrial translocation of Arl4D for organelle homeostasis. Journal of Cell Science, 2026. 139(5): p. jcs264304. 64. Lu, S., et al., Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chemical Society Reviews, 2016. 45(18): p. 4929-4952. 65. Prakash, P., et al., Oncogenic K-Ras binds to an anionic membrane in two distinct orientations: a molecular dynamics analysis. Biophysical journal, 2016. 110(5): p. 1125-1138. 66. Ehrhardt, A., et al., Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen. Molecular and cellular biology, 2004. 24(14): p. 6311-6323. 67. Hastings, J.F., et al., The extracellular matrix as a key regulator of intracellular signalling networks. British journal of pharmacology, 2019. 176(1): p. 82-92. 68. Devreotes, P. and A.R. Horwitz, Signaling networks that regulate cell migration. Cold Spring Harbor perspectives in biology, 2015. 7(8): p. a005959. 69. Pyne, N.J. and S. Pyne, Receptor tyrosine kinase–G-protein-coupled receptor signalling platforms: out of the shadow? Trends in pharmacological sciences, 2011. 32(8): p. 443-450. 70. Pyne, N., et al., Receptor tyrosine kinase–GPCR signal complexes. Biochemical Society transactions, 2003. 31(6): p. 1220-1225. 71. Shin, Y.J., et al., Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac. PLoS One, 2013. 8(8): p. e71495. 72. Park, E.R., S.T. Eblen, and A.D. Catling, MEK1 activation by PAK: a novel mechanism. Cellular signalling, 2007. 19(7): p. 1488-1496. 73. Rashid, T., M. Banerjee, and M. Nikolic, Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. Journal of Biological Chemistry, 2001. 276(52): p. 49043-49052. 74. Daubon, T., R. Buccione, and E. Génot, The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor β-stimulated aortic endothelial cells. Molecular and Cellular Biology, 2011. 31(22): p. 4430-4441. 75. Lee, J.M., et al., Control of protein stability by post-translational modifications. Nature communications, 2023. 14(1): p. 201. 76. Orrico, A., et al., Aarskog–Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene. American Journal of Medical Genetics Part A, 2010. 152(2): p. 313-318. 77. Gao, L., J.L. Gorski, and C.S. Chen, The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells. The American journal of pathology, 2011. 178(3): p. 969-974. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/104658 | - |
| dc.description.abstract | Arl4 小型 GTP 酶(腺嘌呤核苷二磷酸核醣化相似因子四, Arl4)在調控膜相關訊號傳遞與細胞骨架動態中扮演關鍵角色,對於細胞遷移至關重要。然而,調控 Arl4 活化、訊號傳遞以及效應分子調控的分子機制仍未被充分釐清。本研究探討 Arl4 蛋白如何透過自我交互作用、支架蛋白功能以及上游活化機制來協調膜上的訊號傳遞。我們發現,纖連蛋白(fibronectin)刺激可促進質膜上磷脂醯肌醇 4,5-雙磷酸(phosphatidylinositol 4,5-bisphosphate, PI(4,5)P₂)的累積,進而增強 Arl4D 的自我交互作用。此自我交互作用促進下游效應蛋白 p21 活化激酶 1(p21-activated kinase 1, Pak1)的募集,並建立一個正回饋迴路,其中 Pak1 所介導的磷酸化進一步穩定 Arl4D 在質膜上的定位,從而促進細胞遷移。此外,我們證實 Arl4D 作為一個支架蛋白,連結細胞外訊號調節激酶 1/2(extracellular signal-regulated kinase 1/2, Erk1/2)與 Pak1。在血小板衍生生長因子(platelet-derived growth factor, PDGF)刺激下,Arl4D 將 Erk1/2 招募至細胞膜,使 Erk1/2 能夠磷酸化 Pak1 的第 212 位蘇胺酸(Thr212),進而增強細胞遷移相關的訊號。 此外,我們鑑定出含 FYVE、RhoGEF 與 PH 結構域蛋白 1(FYVE, RhoGEF and PH domain–containing protein 1, FGD1)為 Arl4A/D 先前未被辨識的鳥嘌呤核苷酸交換因子(guanine nucleotide exchange factor, GEF)。FGD1 在 PDGF 訊號下調控 Arl4A/D 的活化,建立了生長因子訊號與 Arl4 活化之間的分子連結。總結而言,本研究揭示了一個由膜脂質、激酶訊號以及上游 GEF 活性所組成的整合性調控網絡,用以控制 Arl4 依賴的訊號傳遞與細胞遷移,並提供小型 GTP 酶如何達成空間性組織與訊號特異性的嶄新見解。 | zh_TW |
| dc.description.abstract | Arl4 small GTPases regulate membrane-associated signaling and cytoskeletal dynamics that are critical for cell migration. However, the molecular mechanisms regulating Arl4 activation, signaling transduction, and effector regulation remain poorly understood. In this study, we investigated how Arl4 proteins coordinate membrane signaling through self-interaction, scaffolding functions, and upstream activation mechanisms. We found that fibronectin stimulation promotes the accumulation of PI(4,5)P₂ at the plasma membrane, which enhances Arl4D self-interaction. This self-association facilitates the recruitment of the downstream effector Pak1 and establishes a positive feedback loop in which Pak1-mediated phosphorylation further stabilizes Arl4D on the plasma membrane, thereby promoting cell migration. In addition, we demonstrate that Arl4D functions as a scaffolding protein that bridges Erk1/2 and Pak1. Under PDGF stimulation, Arl4D recruits Erk1/2 to the plasma membrane, enabling Erk1/2-mediated phosphorylation of Pak1 at Thr212, which enhances migratory signaling. Furthermore, we identify FGD1 as a previously unrecognized guanine nucleotide exchange factor (GEF) for Arl4A/D. FGD1 regulates Arl4A/D activation under PDGF signaling, providing a mechanistic link between growth factor signaling and Arl4 activation. Together, these findings reveal a coordinated regulatory network in which membrane lipids, kinase signaling, and upstream GEF activity integrate to control Arl4-dependent signaling and cell migration, and provide new insight into how small GTPases achieve spatially organized and signal-specific functions. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-08-31T16:07:40Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2026-08-31T16:07:40Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | Contents
口試委員會審書 i 誌謝 ii 摘要 iii Abstract iv Contents vi Figure of Contents x Abbreviations xiii 1. Introduction 1 1.1 Small GTPase 1 1.2 ARF and ARL family 2 1.3 Arl4 family 3 1.4 Small GTPase self-interaction 4 1.5 Pak1 (p21-activated kinase 1) 5 1.6 Erk1/2 (Extracellular signal-regulated kinases 1/2) 6 1.7 FGD1 (FYVE, RhoGEF and PH domain–containing protein 1) 7 2. Materials and Methods 9 2.1 Cell Culture 9 2.2 Recombinant protein induction and purification 9 2.3 In vitro binding assay 11 2.4 Co-immunoprecipitation (Co-IP) assay 11 2.5 Immunofluorescence staining 13 2.6 Transient transfection and siRNA-mediated knockdown 14 2.7 PDGF stimulation and pharmacological treatments 14 2.8 Fibronectin coating and adhesion assay 15 2.9 Chemical treatments 15 2.10 Cytosolic, Nuclear and Membrane (CNM) fractionation 15 2.11 Protein extraction and western blot analysis 16 2.12 RNA extraction and RT-PCR 16 2.13 Limited proteolysis assay 17 2.14 Liposome preparation and flotation assay 18 2.15 GST pull-down and activity pull-down assays 19 2.16 Transwell migration assay 20 2.17 GEF assay 21 3. Results 22 3.1 Chapter I: Phosphatidylinositol 4,5-bisphosphate mediates Arl4D self-interaction to promote Pak1 signaling under fibronectin stimulation 22 3.1.1 Arl4D undergoes self-interaction and forms dimers, and selectively interacts with Arl4A 22 3.1.2 Arl4D self-interaction occurs in a GTP-dependent manner 23 3.1.3 Arl4D self-interacts on the plasma membrane but not in the cytosol 24 3.1.4 Fibronectin enhances Arl4D self-interaction to promote membrane targeting without affecting GTP loading 25 3.1.5 Fibronectin-induced PI(4,5)P2 accumulation promotes Arl4D self-interaction 26 3.1.6 Fibronectin-induced PI(4,5)P2 accumulation and Arl4D phosphorylation cooperatively promote Arl4D self-interaction 28 3.1.7 Arl4D self-interaction is required for promoting cell migration 29 3.1.8 Arl4D self-interaction is critical for Pak1 association and effector function 30 3.1.9 Arl4D self-interaction participates in Arl4A–Arl4D–Pak1 complex formation to promote cell migration 31 3.1.10 Arl4D self-interaction increases protein stability at the plasma membrane under fibronectin stimulation 32 3.1.11 Conclusion for Chapter I 34 3.2 Chapter II: The phosphorylation of Pak1 by Erk1/2 to drive cell migration requires Arl4D acting as a scaffolding protein 35 3.2.1 Arl4A/D interact with Erk1/2 and recruit Erk1/2 to the plasma membrane 35 3.2.2 Erk1/2-mediated Pak1 T212 phosphorylation requires Arl4D under PDGF stimulation 36 3.2.3 Arl4D recruits Erk1/2 to the plasma membrane under PDGF stimulation 37 3.2.4 Activated Erk1/2 interacts with Arl4D under PDGF signaling 38 3.2.5 Identification of Arl4D-binding–defective Erk1/2 mutants 39 3.2.6 Arl4D serves as a scaffolding bridge between Erk1/2 and Pak1 40 3.2.7 Pak1 T212 phosphorylation is important for promoting cell migration 41 3.2.8 The Erk1/2–Arl4D–Pak1 complex is required for PDGF-induced cell migration 42 3.2.9 Conclusion for Chapter II 43 3.3 Chapter III: FGD1 is a novel GEF for Arl4A/D 44 3.3.1 Identification of potential GEFs for the Arl4 family 44 3.3.2 FGD1 preferentially binds GDP-bound Arl4A/D and functions as a GEF to regulate cell migration 45 3.3.3 PDGF induces Arl4A/D activation through FGD1 46 3.3.4 AAS-associated FGD1 mutations impair interaction with Arl4A/D 46 3.3.5 FGD1 mutants fail to rescue Arl4A/D activation and function 47 3.3.6 PDGF enhances FGD1 activity through tyrosine phosphorylation 47 4. Discussion 49 4.1 Chapter I: Phosphatidylinositol 4,5-bisphosphate mediates Arl4D self-interaction to promote Pak1 signaling under fibronectin stimulation 49 4.2 Chapter II: The phosphorylation of Pak1 by Erk1/2 to drive cell migration requires Arl4D acting as a scaffolding protein 55 4.3 Chapter III: FGD1 is a novel GEF for Arl4A/D 59 5. Figure 63 6. Supplementary Figure 132 7. SI Appendix 135 8. Reference 138 | - |
| dc.language.iso | en | - |
| dc.subject | 腺嘌呤核苷二磷酸核醣化相似因子四 | - |
| dc.subject | 自我交互作用 | - |
| dc.subject | 磷脂醯肌醇 4,5-雙磷酸 | - |
| dc.subject | p21 活化激酶 1 | - |
| dc.subject | 細胞外訊號調節激酶 1/2 | - |
| dc.subject | 含 FYVE、RhoGEF 與 PH 結構域蛋白 1 | - |
| dc.subject | 膜訊號傳遞 | - |
| dc.subject | Arl4 | - |
| dc.subject | self-interaction | - |
| dc.subject | PI(4,5)P₂ | - |
| dc.subject | Pak1 | - |
| dc.subject | Erk1/2 | - |
| dc.subject | FGD1 | - |
| dc.subject | membrane signaling | - |
| dc.title | Arl4 介導之訊號傳遞功能性特徵分析與膜動態調控機制 | zh_TW |
| dc.title | Functional Characterization of Arl4-Mediated Signaling Transduction in Regulating Membrane Dynamics | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 114-2 | - |
| dc.description.degree | 博士 | - |
| dc.contributor.oralexamcommittee | 劉雅雯;游佳融;陳瑞華;詹迺立;陳光超 | zh_TW |
| dc.contributor.oralexamcommittee | Ya-Wen Liu;Chia-Jung Yu;Ruey-Hwa Chen;Nei-Li Chan;Guang-Chao Chen | en |
| dc.subject.keyword | 腺嘌呤核苷二磷酸核醣化相似因子四; 自我交互作用; 磷脂醯肌醇 4,5-雙磷酸; p21 活化激酶 1; 細胞外訊號調節激酶 1/2; 含 FYVE、RhoGEF 與 PH 結構域蛋白 1; 膜訊號傳遞 | zh_TW |
| dc.subject.keyword | Arl4; self-interaction; PI(4,5)P₂; Pak1; Erk1/2; FGD1; membrane signaling | en |
| dc.relation.page | 145 | - |
| dc.identifier.doi | 10.6342/NTU202601466 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2026-06-26 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 分子醫學研究所 | - |
| dc.date.embargo-lift | 2026-09-01 | - |
| 顯示於系所單位: | 分子醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-114-2.pdf | 48.54 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
